.png
)
CDSCO • Office of DCG(I) • File No. PMDSM-14011(27)/17/2026-eoffice All State/UT Licensing Authorities instructed to ensure PIL and promotional literature updates following SEC (Analgesics & Orthopedics) recommendation. Issued by: Drugs Controller General (India), Post Marketing Drugs Safety Monitoring Division | …
VAAYATH REGULATORY WATCH CDSCO / COSMETICS · 22 JUL 2026 CDSCO Circular · Cosmetics Division CDSCO has directed port officers and State Licensing Authorities to tighten surveillance on imported cosmetics being sold in the domestic market without a valid Import…
CDSCO CIRCULAR 21 JUL 2026 F.NO. LEGAL-13011(11)/17/2026 CDSCO Clarifies Jurisdiction for Compounding of Offences Applications Under Rule 4 A new circular settles which Compounding Authority — Central or State/UT — should receive applications under the Drugs and Cosmetics (Compounding of…
Doc No. CDSCO/MD/GD/MDSW/01/2026 | Circular F. No. MED-16028/2/2025-eoffice dated 21.07.2026 The Central Drugs Standard Control Organization (CDSCO), Medical Devices Division, has notified the final Guidance Document on Medical Device Software (MDSW), signed by Dr. Rajeev Singh Raghuvanshi, Drugs Controller General…
File Ref: Enforc-11021(11)/106/2024 · CDSCO / Maharashtra FDA India's pharma industry has a brand-name problem — and a single antacid brand just showed regulators exactly why it matters. Exhibit A A Notice That Arrived Right on Time On July 6,…